[ Back to EurekAlert! ] Public release date: 25-Nov-2008
[ | E-mail | Share Share ]

Contact: Sharon Reis
sreis@gymr.com
GYMR

New research on PTSD & twins, cognitive-enhancing drugs, sugar-binging and infant temperament

WHAT: A special telebriefing with renowned brain and behavior researchers who will headline the 2008 American College of Neuropsychopharmacology's Annual Meeting

WHO:
Bill Carlezon, PhD, Chair of ACNP's Public Information Committee
Roger Pittman, MD, Harvard Medical School/Mass. General Hospital (PTSD and Twins)
Bart Hoebel, PhD, Princeton University (Sugar-Bingeing)
Nora Volkow, MD, Director of the National Institute of Drug Abuse (Cognitive-Enhancing Drugs)
Carl Schwartz, MD, Harvard Medical School/Mass. General Hospital (Infant Behavior)

WHEN: Thursday, December 4 at 12 noon ET

RSVP: Sharon Reis, sreis@gymr.com, to receive the conference number and news releases

Selected studies include:

Other Highlights Include

###

ACNP, founded in 1961, is a professional organization of more than 700 leading scientists, including four Nobel Laureates. The mission of ACNP is to further research and education in neuropsychopharmacology and related fields in the following ways: promoting the interaction of a broad range of scientific disciplines of brain and behavior in order to advance the understanding of prevention and treatment of disease of the nervous system including psychiatric, neurological, behavioral and addictive disorders; encouraging scientists to enter research careers in fields related to these disorders and their treatment; and ensuring the dissemination of relevant scientific advances.

Email sreis@gymr.com to receive call-in information


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.